NeOnc's Brain Cancer Efforts Bring Hope as FDA Meeting Approaches

Go back to NeOnc's Brain Cancer Efforts Bring Hope as FDA Meeting Approaches
(NASDAQ: NTHI) Delayed: 3.00 +0.10 (3.45%)
Previous Close $2.90    52 Week High $ 
Open $3.00    52 Week Low $ 
Day High $3.03    P/E N/A 
Day Low $2.93    EPS $ 
Volume 41,669